Menu
GeneBe

rs148795690

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_000393.5(COL5A2):c.3837T>C(p.Ile1279=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000949 in 1,614,088 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00061 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00098 ( 1 hom. )

Consequence

COL5A2
NM_000393.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.521
Variant links:
Genes affected
COL5A2 (HGNC:2210): (collagen type V alpha 2 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 2-189039360-A-G is Benign according to our data. Variant chr2-189039360-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 136955.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-189039360-A-G is described in Lovd as [Likely_benign]. Variant chr2-189039360-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.521 with no splicing effect.
BS2
High AC in GnomAd at 94 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
COL5A2NM_000393.5 linkuse as main transcriptc.3837T>C p.Ile1279= synonymous_variant 51/54 ENST00000374866.9
COL5A2XM_011510573.4 linkuse as main transcriptc.3699T>C p.Ile1233= synonymous_variant 54/57
COL5A2XM_047443251.1 linkuse as main transcriptc.3699T>C p.Ile1233= synonymous_variant 56/59
COL5A2XM_047443252.1 linkuse as main transcriptc.3699T>C p.Ile1233= synonymous_variant 55/58

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
COL5A2ENST00000374866.9 linkuse as main transcriptc.3837T>C p.Ile1279= synonymous_variant 51/541 NM_000393.5 P1
COL5A2ENST00000618828.1 linkuse as main transcriptc.2676T>C p.Ile892= synonymous_variant 44/475

Frequencies

GnomAD3 genomes
AF:
0.000618
AC:
94
AN:
152092
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000459
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00106
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000398
AC:
100
AN:
251424
Hom.:
0
AF XY:
0.000353
AC XY:
48
AN XY:
135892
show subpopulations
Gnomad AFR exome
AF:
0.000369
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000783
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000984
AC:
1438
AN:
1461878
Hom.:
1
Cov.:
31
AF XY:
0.000963
AC XY:
700
AN XY:
727240
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
Gnomad4 AMR exome
AF:
0.0000894
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00125
Gnomad4 OTH exome
AF:
0.000662
GnomAD4 genome
AF:
0.000611
AC:
93
AN:
152210
Hom.:
0
Cov.:
31
AF XY:
0.000524
AC XY:
39
AN XY:
74414
show subpopulations
Gnomad4 AFR
AF:
0.000458
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000189
Gnomad4 NFE
AF:
0.00106
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000818
Hom.:
0
Bravo
AF:
0.000650
EpiCase
AF:
0.00125
EpiControl
AF:
0.000771

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Likely benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMar 01, 2021- -
not specified Benign:3
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 24, 2023- -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 23, 2014This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Familial thoracic aortic aneurysm and aortic dissection Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsAug 14, 2015This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Ehlers-Danlos syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenNov 29, 2021- -
Ehlers-Danlos syndrome, classic type, 2 Benign:1
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesJun 19, 2023- -
Ehlers-Danlos syndrome, classic type, 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
Cadd
Benign
6.5
Dann
Benign
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs148795690; hg19: chr2-189904086; API